CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Irinotecan Monotherapy Versus Irinotecan-Based Combination as Second-Line Chemotherapy in Advanced Gastric Cancer: A Meta-Analysis
Yo-Han Cho, So Young Yoon, Soo-Nyung Kim
Cancer Research and Treatment. 2017;49(1):255-262.   Published online 2016 May 18    DOI: https://doi.org/10.4143/crt.2015.452

Excel Download

Irinotecan Monotherapy Versus Irinotecan-Based Combination as Second-Line Chemotherapy in Advanced Gastric Cancer: A Meta-Analysis
Cancer Research and Treatment. 2017;49(1):255-262   Crossref logo
Link1 Link2 Link3

6578 A randomized phase II study of irinotecan monotherapy versus irinotecan plus 5-fluorouracil/leucovorin combination as a salvage chemotherapy in previously treated patients with advanced/metastatic gastric cancer
European Journal of Cancer Supplements. 2009;7(2):383-384   Crossref logo
Link1 Link2

Meta-analysis of biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer
Annals of Oncology. 2018;29:viii228   Crossref logo
Link1 Link2 Link3

Second-line chemotherapy with irinotecan plus cisplatin after the failure of S-1 monotherapy for advanced gastric cancer
Gastric Cancer. 2010;13(3):186-190   Crossref logo
Link1 Link2 Link3

Meta-analysis of two randomized phase III trials (TCOG GI-0801 and ECRIN TRICS) of biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer
Gastric Cancer. 2019;23(1):160-167   Crossref logo
Link1 Link2 Link3

SO13P�META-ANALYSIS OF IRINOTECAN MOLECULAR TARGETED SECOND LINE CHEMOTHERAPY IN ADVANCED COLORECTAL CANCER
ANZ Journal of Surgery. 2009;79:A82-A82   Crossref logo
Link1 Link2

Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trial
European Journal of Cancer. 2015;51(7):808-816   Crossref logo
Link1 Link2

P-088 Evaluation of prognostic and predictive factors in second-line treatment with irinotecan based chemotherapy in gastric cancer
Annals of Oncology. 2015;26:iv25   Crossref logo
Link1 Link2 Link3

A randomized phase II study of biweekly irinotecan monotherapy or a combination of irinotecan plus 5-fluorouracil/leucovorin (mFOLFIRI) in patients with metastatic gastric adenocarcinoma refractory to or progressive after first-line chemotherapy
Cancer Chemotherapy and Pharmacology. 2012;71(2):481-488   Crossref logo
Link1 Link2 Link3

Third-Line Weekly Docetaxel Chemotherapy in Advanced Gastric Cancer Who Failed Previous Fluoropyrimidine and Irinotecan or Oxaliplatin-Based Chemotherapies
Annals of Oncology. 2014;25:iv230   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.